To explore the frequency of Joint Hypermobility Syndrome (JHS) among university students and assess whether a relationship exists between this collagen condition and certain psychological variables.
Method:
A cross-sectional sample of 365 undergraduates at a French university was assessed with the Brighton's criteria for JHS, Somatosensory Amplification Scale (SSAS), Liebowitz Social Anxiety Scale (LSAS), and Hospital Anxiety and Depression Scale (HADS).
Results:
39.5% of the participants met Brighton's criteria for JHS. Scores of somatosensory amplification were higher among participants with JHS (t = −2.98; p = 0.03) independent of gender. Female participants with JHS had higher scores in depression (t = −2.01; p = 0.04) and general anxiety (t = −2.35; p = 0.01) than women without JHS. The percentage of males with a medium/high level of social anxiety was greater among participants with JHS (78.6% vs. 41.7%; χ2 = 6.18; p = 0.01). Logistic regression demonstrated that male sex and low level of somatosensory amplification are variables contrary to the presence of JHS.
Conclusion:
JHS is a frequent condition among young people evaluated. JHS is associated with psychological distress and higher levels of somatosensory amplification.
HakimAGrahameR. Joint hypermobility. Best Practice & Research Clinical Rheumatology2003; 17: 989–1004.
2.
BravoJF. Joint hypermobility syndrome: The most frequent cause of pain in rheumatological practice? Retrieved April 21, 2010, from http://www.medscape.com/viewarticle/537960
3.
GrahameR. Pain, distress and joint hyperlaxity. Joint Bone Spine2000; 67: 157–163.
4.
BravoJWolffC. Clinical study of hereditary disorders of connective tissues in a Chilean population: Joint hypermobility syndrome and vascular Ehlers-Danlos syndrome. Arthritis and Rheumatism2006; 54: 515–523.
5.
GumàMOlivéAHolgadoSCasadoERocaJForcadaJ. Una estimación de la laxitud en la consulta externa. Revista Española de Reumatología2001; 28: 298–300.
6.
WatsonDClarkLAWeberKAssenheimerJCStraussMEMcCormickRA. Testing a tripartite model: II. Exploring the symptom structure of anxiety and depression in student, adult, and patient samples. Journal of Abnormal Psychology1995,104: 15–25.
7.
Baeza-VelascoCBulbenaA. The relationship between anxiety and joint hypermobility: Literature review. Annales Médico Psychologiques2010; 168: 263–267.
8.
Martín-SantosRBulbenaAPortaMGagoJMolinaLDuróJ. Association between joint hypermobility syndrome and panic disorder. American Journal of Psychiatry1998; 155: 1578–1583.
BulbenaAGagoJSperryLBergeD. The relationship between frequency and intensity of fears and collagen condition. Depression and Anxiety2006; 23: 412–417.
11.
GülsünMDorukAUzunOTonbulM. Eklem hipermobilite sendromu olan klinic disi erkek örnekleminde anksiyete bozukluklari. Yeni Symposium Journal2006; 44,165–168.
12.
GülsünMYilmazMBPinarMTonbulMCelikCOzdemirB. Thorax deformity, joint hypermobility and anxiety disorders. Saudi Medical Journal2007; 28: 1840–1844.
13.
Baeza-VelascoCBulbenaABravoJF. Anxious symptomatology and Joint Hyper-mobility Syndrome (JHS) in a group of Chilean undergraduate students. Ansiedad y Estrés2010; 16: 1–12.
14.
GagoJ. Estudio de Prevalencias y Asociación de Laxitud Articular y Trastornos Ansiosos-Fóbicos en el medio Rural. Tesis doctoral. Facultad de Medicina, Universidad Autónoma de Barcelona, 1992.
15.
Baeza-VelascoCBulbenaA. Social anxiety and collagen-altering condition in high stature people. Cuadernos de Medicina Psicosomática y Psiquiatría de Enlace2009; 89/90: 40–46.
16.
GratacòsMNadalMMartín-SantosRPujanaMAGagoJPeralB. A polymorphic genomic duplication on human chromosome 15 is a susceptibility factor for panic and phobic disorders. Cell2001; 106: 367–379.
17.
Neergaard-HenrichsenCDelormeRBoucherieMMarelliDBaudPBellivierF. No association between DUP25 and anxiety disorders. American Journal of Medical Genetics Part B Neuropsychiatric Genetics2004; 128; 80–83.
18.
SchumacherJOtteABeckerTSunYWienkerTWirthB. No evidence for DUP25 in patients with panic disorder using a quantitative real-time PCR approach. Human Genetics2003; 114: 115–117.
19.
TabinerMYouingsSDennisNBaldwinDBuisCMayersA. Failure to find DUP25 in patients with anxiety disorders, in control individuals, or in previously reported positive control cell lines. American Journal of Human Genetics2003; 72: 535–538.
20.
LumleyMJordanMRubensteinRTsipourasPEvansM. Psychosocial functioning in the Ehlers-Danlos syndrome. American Journal of Medical Genetics2005; 53: 149–152.
21.
FishbainDCutlerRRosomoffHRosomoffR. Chronic pain-associated depression: Antecedent or consequence of chronic pain? A review. The Clinical Journal of Pain1997; 13: 116–137.
22.
ErcolaniMGalvaniMFranchiniCBaracchiniFChattatR. Benign joint hypermobility syndrome: Psychological features and psychopathological symptoms in a sample pain-free at evaluation. Perceptual and Motor Skills2008; 107: 246–256.
23.
BarskyAJGoodsonJDLaneRSClearyPD. The amplification of somatic symptoms. Psychosomatic Medicine1988; 50: 510–519.
24.
BarskyAJ. Amplification, somatization, and the somatoform disorders. Psychosomatics1992; 33: 28–34.
25.
BellochAAyllónEMartínezMPCastañeirasCJiménezMA. Sensibilidad a las sensaciones corporales e hipocondría. Revista de Psicopatología y Psicología Clínica1999; 4: 1–14.
26.
BeightonPHSolomonLSoskolneCL. Articular mobility in an African population. Annals of the Rheumatic Disease1973; 32: 413–417.
27.
GrahameRBirdHAChildA. The revised (Brighton, 1998) criteria for the diagnosis of benign joint hypermobility syndrome (BJHS). Journal of Rheumatology2000; 27: 1777–1779.
28.
ZigmondASnaithR. The Hospital Anxiety and Depresión Scale. Acta de Psiquiatría Escandinava1983; 67: 361–370.
29.
LépineJPGodchauMBrunPLemperièreT. Evaluation de l'anxiété et de la dépression chez des patients hospitalisés dans un service de médecine interne. Annales Médico Psychologiques1985; 143: 175–189.
30.
LiebowitzM. Social phobia. In KleinDF, editor, Anxiety (pp. 141–173). New York: Karger; 1987.
31.
YaoSNNoteIFangetFAlbuissonEBouvardMJalenquesICottrauxJ. Social anxiety in patients with social phobia: Validation of the Liebowitz Social Anxiety Scale: The French version. L'Encéphale1999; 25: 429–435.
32.
BarskyAJWyshakGKlermanGL. The somatosensory amplification scale and its relationship to hypochondriasis. Journal of Psychiatric Research1990; 24: 323–324.
33.
BridouMAguerreC. Qualités psychométriques de la version française de l'échelle d'amplification somatosensorielle de Barsky. Congress of the French Psychological Society (SFP), Bordeaux, Sept. 2008.
34.
GrahameRHakimAJ. High prevalence of joint hypermobility syndrome in clinic referrals to a north London community hospital. Rheumatology2004; 43(Supp 2): 91.
35.
GrahameR. The need to take a fresh look at criteria for hypermobility. The Journal of Rheumatology2007; 34: 664–665.
36.
BulbenaABenitoPPailhezGGagoJCarbonellJSperryL. Hiperlaxitud articular, definición y exploración. Programa interactivo de formación (Cd room). Barcelona: Institut d'Atenció Psiquiàtrica Salud Mental i Toxicomanies Hospital del Mar, Barcelona, 2004.
37.
MenéndezF. De la laxitud a la hipermovilidad articular. Revista Cubana de Reumatología2005; 7: 7–8.
38.
TrivediMH. The link between depression and physical symptoms. Primary Care Companion Journal of Clinical Psychiatry2004; 6(Suppl 1): 12–16.
39.
NakaoMBarskyAJKumanoHKubokiT. Relationship between somatosensory amplification and alexithymia in a Japanese psychosomatic clinic. Psychosomatics2002; 43: 55–60.
